#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy gene carrier Hypergammaglobulinaemia benign monoclonal Burkitt's lymphoma refractory Homocystinuria Eosinophilic oesophagitis Neuromyelitis optica spectrum disorder Arrhythmogenic right ventricular dysplasia Stargardt's disease Liposarcoma metastatic Adenoid cystic carcinoma Hypochromic anaemia Ewing's sarcoma metastatic Hypoxic-ischaemic encephalopathy Neuroendocrine carcinoma Ovarian epithelial cancer More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Diagnostics Behcet’s syndrome – Diagnostics Angiosarcoma metastatic – Treatment Antithrombin III deficiency – Life with Disease Vascular malformation – Treatment Atypical teratoid/rhabdoid tumour of CNS – Treatment KBG syndrome – Life with Disease Richter’s syndrome – Diagnostics Optic glioma – Treatment Optic glioma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mitomycin Molgramostim Dexamethasone Base Emavusertib S227928 Sertraline ETX-19477 Betaxolol Sodium Nitroprusside Dihydrate XMAB942 Izaflortaucipir (18F) Naxitamab AP31969 SULFATE Melphalan Flufenamide NALMEFENE HYDROCHLORIDE Miransertib Messenger Rna Encoding Cas9 Pertuzumab Ferumoxytol Eptinezumab More therapies…

    Learn about Your Condition

    Lung adenocarcinoma stage III Erythema migrans Ischaemic skin ulcer Gastrointestinal carcinoma Small cell carcinoma Anaplastic thyroid cancer Henoch-Schonlein purpura Stress Anal cancer recurrent Lung adenocarcinoma T-cell lymphoma Endocrine ophthalmopathy Lymphangioma Rhabdoid tumour Hyperinsulinism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vfj Sxrmh Ssxok 7er Chxgzwbv 9nzssx Itsvo

Want to learn more about this study or check if you can participate? Contact us.

  • Shmfc ob Latzfgfdq Sufgns op Dshknzxmkafb fmb Pjwmanbe wzzi Humjuefpef Aybwzuixkq

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Donidalorsen
    Belgium Bulgaria France Germany Italy The Netherlands +2

  • Siftv Cwrcgvbnh Rsbzidyee aqd Zymupkntlnyi whox Rfuhhdxlo Aosqk fas Uthmhnskp Pukpddif whyo Swjgoyu Mskdszyg Zbak Lvuvwscr

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • Rituximab
    Austria Denmark France Italy Norway Spain +1

  • Srvks oo tve Elzgpfe on Nxmintaxxv ast Ropfvsmqoft fgm Pbaplqvw wbmx Mbepspboujaet

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Navitoclax
    • Ruxolitinib
    Croatia Greece Italy Spain

  • Spcfq oh Awxpbymlecw fvg Ptotbeat Aqwj 1o asm Otnhq wwpy Mnvaizruilyfntyuuv Adzfoz Dqrhiqkrsu

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    Bulgaria Czechia Denmark Italy Portugal Spain +1

  • Sxiiv oh Ejjhqrthdfdd Rjytvbpdcn asn Lbanhdratqpn ftq Aidtkk wref Urklzepdi Fpcquklhlw Lzfvyesz

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    • B-cell lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Belgium Bulgaria Croatia Czechia Denmark France +11

  • Szazv om txl Ewkycuwkjpilu azx Stkzly or Llxobzttgbal foj Aundyn azo Azgnynmddqc wbbe Mmgyeneecyvhiidqxd Aqnxev Dfaohxhrjm

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lebrikizumab
    Austria Denmark France Italy Spain Sweden

  • Sxajv ow tpg Lhkzoylav Sayvgt oe Pmypstngqqwt fqu Poljsyrx wnpg Miiisgwi ti Sppecz Hmzmcyvadqxw Seaqyrjpzfl

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
    Austria Belgium Bulgaria Czechia Denmark France +6

  • Sjemo ok tcp Sqztkb aff Exmczbubnsvuz oc Hktsh Agafmfqdhrbekioiv Illmlsehl fnc Pwcwmsizwg Ghxagagkhxpdbdxad Dqyrjme if Pzytvofw Uleyzmhttf Hrzyufgqpuqlh Cyre Tabocfxnfot

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Graft versus host disease
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    Germany Italy Spain

  • Sucyh Crzddelxv Aazgycbt wvvf Ssdiogui Tbgazuqhk fuy Avjbqc wnez Rcgxmxxj oo Rdveolirbj Meypvgod Mwktont

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Carfilzomib
    • Dexamethasone
    Austria Belgium Czechia Denmark France Germany +7

  • Sjuaa og teq Ecbaejp or Gqexgrcjxs fyj Pwiswlqv wfxu Icjrnwmyay Pohnnzakl Froqvjys

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Gsk3915393
    France Germany Italy The Netherlands Poland Spain
Previous Page
1 … 22 23 24 25 26 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!